Technical Analysis for XBIT - XBiotech Inc.

Grade Last Price % Change Price Change
grade A 10.6 7.72% 0.76
XBIT closed up 7.72 percent on Tuesday, March 19, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical XBIT trend table...

Date Alert Name Type % Chg
Mar 19 Multiple of Ten Bullish Other 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 19 Up 3 Days in a Row Strength 0.00%
Mar 18 180 Bullish Setup Bullish Swing Setup 7.72%
Mar 18 Earnings Movers Other 7.72%
Mar 18 Wide Bands Range Expansion 7.72%
Mar 15 20 DMA Support Bullish 15.59%
Mar 15 Earnings Movers Other 15.59%
Mar 15 Wide Bands Range Expansion 15.59%
Mar 14 MACD Bearish Signal Line Cross Bearish 16.61%

Older signals for XBIT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
XBiotech, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing “True Human™” monoclonal antibodies for treating various different diseases. Its lead product is Xilonix, which is in II Phase III clinical trials for the treatment of colorectal cancer in the United States and Europe. The company also develops MABp1, a therapeutic antibody, which neutralizes interleukin-1 alpha; and completed a Phase I/II clinical trials for MABp1 as a treatment for cancer. In addition, it investigates MABp1 in clinical trials for other indications, including vascular disease, type II diabetes, acne, and psoriasis. XBiotech, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Biopharmaceutical Cancer Medical Specialties Life Sciences Alpha Drugs Antibodies Monoclonal Antibodies Psoriasis Acne Colorectal Cancer Ii Diabetes Vascular Disease Monoclonal Antibody Therapy Treatment For Cancer Mm 151 Treatment Of Colorectal Cancer
Is XBIT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.85
52 Week Low 2.13
Average Volume 174,728
200-Day Moving Average 5.0071
50-Day Moving Average 7.8254
20-Day Moving Average 9.2185
10-Day Moving Average 9.839
Average True Range 0.8446
ADX 16.75
+DI 26.0354
-DI 16.8124
Chandelier Exit (Long, 3 ATRs ) 8.3162
Chandelier Exit (Short, 3 ATRs ) 10.1338
Upper Bollinger Band 10.8745
Lower Bollinger Band 7.5625
Percent B (%b) 0.92
BandWidth 35.927754
MACD Line 0.6032
MACD Signal Line 0.6234
MACD Histogram -0.0203
Fundamentals Value
Market Cap 375.45 Million
Num Shares 35.4 Million
EPS -1.46
Price-to-Earnings (P/E) Ratio -7.26
Price-to-Sales 0.00
Price-to-Book 2.03
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.01
Resistance 3 (R3) 11.90 11.33 11.78
Resistance 2 (R2) 11.33 10.97 11.38 11.70
Resistance 1 (R1) 10.96 10.75 11.15 11.07 11.62
Pivot Point 10.39 10.39 10.48 10.44 10.39
Support 1 (S1) 10.02 10.03 10.21 10.13 9.58
Support 2 (S2) 9.45 9.81 9.50 9.50
Support 3 (S3) 9.08 9.45 9.43
Support 4 (S4) 9.19